share_log

Iterum Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dunne Michael W.

SEC ·  Jul 3, 2023 07:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more